the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Assistant secretary’s false claim trial to start Oct 7

KUALA LUMPUR: The trial of an assistant secretary from a ministry, charged with 11 counts of submitting over RM6,000 in false claims will start on Oct 7 in the Sessions Court.

Judge Rozina Ayob set the date after deputy public prosecutor Mohd Shahrom Idris informed the court that the representation submitted by Ku Aznal Shahri Ku Abd Hamid, 49, had been dismissed by the Attorney General’s Chambers (AGC).

“Approximately 24 prosecution witnesses are expected to testify,“ said Mohd Shahrom. Following this the court scheduled eight days for the trial, from Oct 7 to 10 and Nov 18 to 21.

The accused’s lawyer, Tabian Tahir did not object to the dates and confirmed that his client maintains a plea of not guilty.

“For the court’s information, my client is still employed as a civil servant and has not been suspended from duty,“ he said.

On March 5, Ku Aznal Shahri, who was serving as the chief assistant secretary of the Information Technology Management Division at the Ministry of Home Affairs in Putrajaya at the time, was charged with making false claims.

The claims involved the rental of five hotels for RM5,344, travel allowances of RM645.50, and toll payments of RM63.40, all amounting to RM6,052.90.

The offences were allegedly committed at the ministry’s office in Putrajaya, between May 2 and Aug 7, 2018.

The charges under Section 18 of the Malaysian Anti-Corruption Commission (MACC) Act 2009 are punishable by imprisonment of up to 20 years and a fine of not less than five times the amount or value of the bribe or RM10,000, whichever is higher, upon conviction.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings